万古霉素给药指南依从性混合方法研究
该混合方法研究通过回顾性审计163例接受万古霉素治疗≥48小时的患者,评估给药与治疗药物监测(TDM)与机构指南的一致性,并对17名处方者进行半结构化访谈。结果显示仅24%的疗程起始负荷剂量与指南一致,初始维持剂量一致率为42%,且多数谷浓度未调整剂量。尽管处方者知晓指南,模拟场景中仅37%的决策符合推荐。
要点
- 仅24%疗程起始负荷剂量与指南一致,72%低于推荐。
- 初始维持剂量一致率42%,34%低于推荐。
- 60%次治疗浓度和43%超治疗浓度未调整剂量。
核心结论
- 万古霉素给药和TDM与机构指南的依从性差,尽管处方者知晓指南存在。
- 需要多维度策略支持处方者决策以改善万古霉素给药和监测。
研究设计与样本
- 回顾性审计163例接受万古霉素治疗≥48小时的患者,收集患者特征、给药史及血浆万古霉素和肌酐浓度。
- 对17名处方者进行半结构化访谈,包括模拟处方场景,并分析转录文本。
主要发现
- 共收集179个疗程中1043个血浆万古霉素浓度。
- 仅24%的疗程起始负荷剂量与指南一致,其中72%低于推荐。
- 初始维持剂量在42%的疗程中与指南一致,其中34%低于推荐。
- 仅14%的TDM样本为谷浓度万古霉素。
- 60%(21/35)的次治疗浓度和43%(18/42)的超治疗浓度未调整剂量。
关键数值与推荐
- 机构指南推荐条款的具体数值未在摘要中报告。
临床怎么用
- 临床药师应关注万古霉素负荷剂量和维持剂量的指南一致性,并促进谷浓度监测。
- 对次治疗或超治疗浓度应及时调整剂量,避免剂量调整不足。
局限性
- 摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Despite the availability of international consensus guidelines, vancomycin dosing and therapeutic drug monitoring (TDM) remain suboptimal. This study aimed to assess concordance of vancomycin dosing and TDM with institutional guidelines and to identify factors taken into consideration by clinicians when prescribing vancomycin. METHODS: A retrospective audit of 163 patients receiving vancomycin therapy (≥48 hours) was undertaken. Data collected included patient characteristics, dosing history and plasma vancomycin and creatinine concentrations. Concordance of dosing and TDM with institutional guidelines was evaluated. Semi-structured interviews, including simulated prescribing scenarios, were undertaken with prescribers (n = 17) and transcripts analysed. RESULTS: Plasma vancomycin concentrations (n = 1043) were collected during 179 courses of therapy. Only 24% of courses commenced with a loading dose with 72% lower than recommended. The initial maintenance dose was concordant in 42% of courses with 34% lower than recommended. Only 14% of TDM samples were trough vancomycin concentrations. Dose was not adjusted for 60% (21/35) of subtherapeutic and 43% (18/42) of supratherapeutic trough vancomycin concentrations, respectively. Interview participants reported that patient characteristics (including renal function), vancomycin concentrations, guidelines and expert advice influenced vancomycin prescribing decisions. Despite referring to guidelines when completing simulated prescribing scenarios, only 37% of prescribing decisions aligned with guideline recommendations. CONCLUSION: Poor compliance with institutional vancomycin guidelines was observed, despite prescriber awareness of available guidelines. Multifaceted strategies to support prescriber decision-making are required to improve vancomycin dosing and monitoring.
引用
- Carland JE, Stocker SL, Baysari MT, et al. Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices. Br J Clin Pharmacol. 2021. PMID: 33769612. doi:10.1111/bcp.14834
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。